Search - tctmd.com

Displaying 21 - 40 of 41

Sort: Relevancy | Date

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Podcast

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

May 17, 2017

News Conference News EuroPCR 2016

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

Yael L. Maxwell

May 17, 2016

News Conference News ACC 2016

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

Todd Neale

April 04, 2016

News Conference News ACC 2016

Watchman Left Atrial Appendage Closure Device Fares Well in Early Commercial Experience

Todd Neale

April 03, 2016

News Daily News

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Shelley Wood

February 08, 2016

Presentation Scripps 2016

Putting It All Together: Warfarin, NOAC or LAA Closure?

Presenter: Brian K. Whisenant

February 04, 2016

News Daily News

La FDA Da la Voz de Alarma sobre el Uso del Dispositivo Lariat para el Cierre del AAI en Pacientes con FA

Yael L. Maxwell

July 17, 2015

News Daily News

FDA对在房颤患者中使用Lariat左心耳封堵装置发出警示

Yael L. Maxwell

July 17, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Daily News

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Yael L. Maxwell

June 17, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Meta 分析表明 Watchman 依旧不逊于华法林，患者结局良好及安全

Yael L. Maxwell

June 17, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

News Industry News

University of Michigan Health System among first in nation to use new device for stroke prevention

May 15, 2015

News Daily News

Sutureless Valve Shows Encouraging Results in Aortic Stenosis Patients

Yael L. Maxwell

May 01, 2014

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

Advertisement

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

Watchman Left Atrial Appendage Closure Device Fares Well in Early Commercial Experience

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Putting It All Together: Warfarin, NOAC or LAA Closure?

La FDA Da la Voz de Alarma sobre el Uso del Dispositivo Lariat para el Cierre del AAI en Pacientes con FA

FDA对在房颤患者中使用Lariat左心耳封堵装置发出警示

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Meta 分析表明 Watchman 依旧不逊于华法林，患者结局良好及安全

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

University of Michigan Health System among first in nation to use new device for stroke prevention

Sutureless Valve Shows Encouraging Results in Aortic Stenosis Patients

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content